peptide purity is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-05-13. Numbers and descriptions here follow the published literature rather than marketing material.
Ipamorelin 是一种合成五肽，序列为 Aib-His-D-2-Nal-D-Phe-Lys-NH2，分子式 C38H49N9O5，游离碱分子量约 711.85 g/mol。它属于生长激素促分泌素（GHS）家族，作用靶点是胃饥饿素受体 GHS-R1a。该化合物由诺和诺德的研究团队在二十世纪九十年代末报道，设计目标是提高对生长激素释放的选择性。C 端酰胺化与 N 端 Aib 残基是两个用于抵抗肽酶降解的结构特征。
在 GHS 家族中，早期肽类如 GHRP-6 与 GHRP-2 会同时促进生长激素、皮质醇与催乳素的释放，并明显增加食欲。Ipamorelin 在动物与早期人体研究中表现出对生长激素释放的相对选择性，对上述其他激素的影响较小。这种差异通常归因于受体结合模式与下游信号偏向的不同，而完整的分子解释仍有待补充。需要区分的是，选择性是研究观察中的相对程度，并非绝对界限。
Mass spectrometry confirms identity and reveals structural deviations that chromatography alone can miss. Positive-mode electrospray ionisation generally yields multiply charged ions whose deconvoluted mass is checked against the theoretical value. Amino acid analysis, and enzymatic digestion with subsequent fragment mapping, provide independent confirmation of sequence and of the terminal amide. Analysts take care to separate the target from deletion sequences, which may differ by one residue and therefore by only a small mass increment.
The lyophilised solid is normally held at -20 °C or colder, shielded from light and moisture. Stability in that state is measured in years, although shelf life depends on residual water content and the container seal. Once dissolved, the peptide is more fragile: aqueous solutions are commonly kept at 2-8 °C and used within days to weeks, and repeated freeze-thaw cycling is avoided. Strongly acidic or basic conditions accelerate hydrolysis, and prolonged exposure to them can strip the terminal amide.
Purity assessment for this peptide relies mainly on reversed-phase high-performance liquid chromatography. A C18 column with a water-acetonitrile gradient containing trifluoroacetic acid separates the target from truncated sequences and oxidation products. Detection near 214 nm exploits the amide backbone, while the aromatic side chains allow additional monitoring close to 280 nm. Reported purity values depend on the method, so a certificate of analysis carries weight only when gradient, column and integration parameters are given.
| Property | Value | Notes |
|---|---|---|
| 分子式 | C38H49N9O5 | 五肽，C 端酰胺化 |
| 分子量 | 约 711.85 g/mol | 游离碱形式 |
| 外观 | 白色至类白色冻干粉 | 研究用材料的常见形态 |
| 溶解性 | 溶于水及 DMSO 等极性溶剂 | 建议现配现用 |
| 储存温度 | -20 °C 或更低 | 干燥、避光、限制冻融次数 |
现有文献多来自小规模、短期的研究，涉及生长激素缺乏、术后肠麻痹等方向。长期使用是否导致受体脱敏，以及重复给药后效应是否衰减，仍属开放问题。不同研究之间的剂量、给药途径和受试者特征差异较大，因此结论外推需谨慎。关于临床获益的确切证据尚不充分，需要更大规模的对照试验来澄清。
Ipamorelin 是一种合成五肽，在 20 世纪 90 年代被报道为生长激素促分泌剂。其结构基于胃饥饿素受体激动剂的设计思路，但并非天然激素。早期药理学研究显示，它可刺激垂体释放生长激素，而对应激激素轴的影响相对较小。该化合物常被用作研究生长激素调节通路的工具分子。
在机制层面，ipamorelin 与生长激素促分泌受体 1a 型结合，该受体也介导胃饥饿素的多种效应。受体激活后，细胞内信号促进生长激素从垂体前叶释放。由于对促肾上腺皮质激素和皮质醇的刺激较弱，它被视为选择性较高的促分泌剂。这种选择性在动物模型和少量人体研究中被观察到，但人体数据仍然有限。
Storage recommendations for ipamorelin usually focus on temperature, moisture, and light. Lyophilized powder is typically held at or below minus twenty degrees Celsius in a desiccated container protected from light. Reconstituted solutions are often aliquoted and stored at minus eighty degrees Celsius to reduce repeated freeze-thaw cycles, which can promote aggregation or degradation. The optimal buffer and pH depend on the specific assay, and no single condition applies to every experimental context. Peptide stability should be assessed with time-point measurements rather than assumed from general handling rules.
In the scientific literature, ipamorelin appears mainly in preclinical studies, receptor binding assays, and reviews of growth hormone secretagogues. Authors often discuss its selectivity profile alongside limitations such as small sample sizes, short study durations, and differences between species. Some papers examine pharmacokinetics and clearance, but human data are limited and not sufficient to define general clinical effects. Regulatory discussion treats the compound as an investigational or research substance rather than an approved therapy in most jurisdictions. Open questions include oral bioavailability, long-term endocrine effects, and whether selectivity observed in animals persists in humans.
Quality control for research-grade ipamorelin is not governed by a single harmonized pharmacopeial monograph, so certificates of analysis vary between suppliers. Common tests include appearance, solubility, water content, peptide content by quantitative amino acid analysis, and residual counterion measurement. Independent verification by an outside laboratory is often used to confirm identity and purity claims. Salt form, counterion content, and residual solvent levels are frequently unspecified, which complicates direct comparison between lots and leaves reproducibility partly unresolved.
Identity and purity assessment of ipamorelin relies mainly on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometers, a wavelength where the peptide backbone absorbs. Mass confirmation is typically obtained by electrospray ionization mass spectrometry or by liquid chromatography coupled to mass spectrometry, comparing the observed mass with the calculated value. Amino acid analysis and peptide mapping after enzymatic digestion can confirm the sequence. Impurity profiles include deletion peptides, truncated fragments, and oxidation products, reported as relative area percentages.
Compared with older secretagogues such as hexarelin or GHRP-6, ipamorelin shows weaker stimulation of cortisol, prolactin, and appetite in the animal models used for early characterization. Whether that selectivity is preserved across longer human exposures remains an open question, because published clinical data are limited in size and duration. Reported effects on food intake are generally described as modest. The compound is therefore treated in the literature as a relatively selective research tool rather than a fully characterized therapeutic agent.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class of compounds. Researchers at a pharmaceutical company first described it in the 1990s while screening small peptides for growth hormone releasing activity. Its chain contains five amino acid residues, two of which are non-natural building blocks, including 2-aminoisobutyric acid and a naphthylalanine derivative. The molecule was designed to act at the ghrelin receptor while avoiding several effects observed with earlier secretagogues.
=== Human Diseases and Gene Mutations === Greenspan has conducted various research projects directly on the molecular bases of human diseases. A collaborative study with a group at Jefferson Medical College showed mutations in the COL7A1 gene, for type VII collagen, to be the basis of the disabling and fatal skin disease dystrophic epidermolysis bullosa These studies also led to elucidation of the complete intron-exon structure of COL7A1 which at the time had more exons than any previously described gene. His lab was the first to clone and characterize the α1 chain of type V collagen and was also key in the first demonstration that mutations in a type V collagen gene can cause the heritable connective tissue disorder classic Ehers-Danlos syndrome. Accompanying and following these studies, the Greenspan lab has performed studies on collagen V genes and on the biosynthesis of type V collagen and on the molecular mechanisms whereby mutations in type V collagen result in defects in mammalian tissues. Their studies have also shown autoimmunity against type V collagen to be involved in organ transplant rejection and atherosclerosis, and that induction of immune tolerance to type V collagen can help ameliorate atherosclerosis. The Greenspan lab was also the first to clone and characterize the α3 chain of type V collagen and showed the α3(V) chain to be important to the functioning of certain highly specialized cell types and to be important to tumor growth and survival times in breast cancer.
South Africa manufactured several complete nuclear weapons in the 1980s, but during the 1990s, it became the only country to eliminate its domestically produced nuclear arsenal, and abandon further nuclear weapon production. Nuclear weapons have been detonated on over 2,000 occasions for various testing purposes. Countries have increased their readiness to carry out strategic and tactical nuclear attacks in response to intensifying conflicts, including the Korean War, First and Second Taiwan Strait Crises, Cuban Missile Crisis, Vietnam War, Sino-Soviet border conflict, Yom Kippur War, Gulf War, and Russo-Ukrainian war. The 1962 Cuban Missile Crisis, between the nuclear superpowers of the U.S. and Soviet Union, is often considered the closest call with a nuclear exchange and possible World War III. Additionally, nuclear attack early warning systems have sometimes produced false alarms, increasing the risk of nuclear war, such as Soviet satellites in 1983 and Russian radar in 1995. After the dissolution of the Soviet Union in 1991 and the resultant end of the Cold War, the threat of a major nuclear war between the U.S. and Soviet Union has declined. Concern shifted to the prevention of localized nuclear conflicts resulting from nuclear proliferation, and the threat of nuclear terrorism. However, the threat of nuclear war is considered to have resurged since the start of the current phase of the Russo-Ukrainian war in 2022, particularly with regard to Russian threats to use nuclear weapons during the war.
AT-121 is an experimental analgesic. It was designed to be bifunctional, acting as an agonist at both the μ-opioid receptor and the nociceptin receptor. The interaction with the nociceptin receptor is expected to block the abuse and dependence-related side effects that are typical of opioids. A study in nonhuman primates found that AT-121 has morphine-like analgesic effects, but suppressed the addictive effects.
Radon was discovered in 1899 by Ernest Rutherford and Robert B. Owens at McGill University in Montreal. It was the fifth radioactive element to be discovered, after uranium, thorium, radium, and polonium. In 1899, Pierre and Marie Curie observed that the gas emitted by radium remained radioactive for a month. Later that year, Rutherford and Owens noticed variations when trying to measure radiation from thorium oxide. Rutherford noticed that the compounds of thorium continuously emit a radioactive gas that remains radioactive for several minutes, and called this gas "emanation" (from Latin: emanare, to flow out, and emanatio, expiration), and later "thorium emanation" ("Th Em"). In 1900, Friedrich Ernst Dorn reported some experiments in which he noticed that radium compounds emanate a radioactive gas he named "radium emanation" ("Ra Em"). In 1901, Rutherford and Harriet Brooks demonstrated that the emanations are radioactive, but credited the Curies for the discovery of the element. In 1903, similar emanations were observed from actinium by André-Louis Debierne, and were called "actinium emanation" ("Ac Em"). Several shortened names were soon suggested for the three emanations: exradio, exthorio, and exactinio in 1904; radon (Ro), thoron (To), and akton or acton (Ao) in 1918; radeon, thoreon, and actineon in 1919, and eventually radon, thoron, and actinon in 1920.
Sources: en.wikipedia.org
== Essential amino acids in plant food == Essential amino acids (EAAs) are the amino acids required by an organism for building proteins but which cannot be synthesized by the organism itself. As such it is essential that these amino acids be supplied by the organism's diet. In case of humans there are 9 EAAs: histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine. EAAs are provided in both animal and plant-based food. The EAAs in plants vary greatly due to the vast variation in the plant world and, in general, plants have much lower content of proteins than animal food. Some plant-based foods contain few or no EAAs, e.g. some sprouts, mango, pineapple, lime and melon. On the other hand, nuts, seeds, beans and peas contain EAAs in significant quantity. The following table shows the composition of EAAs in selected plant foods as well as recommended dietary allowances.(RDA)
The founding of the Zulu Kingdom was precipitated by the Mfecane, a period of widespread instability and state formation in Southern Africa, caused by pre-existing trends of political centralisation which were catalysed by the effects of international trade, environmental instability, and European colonial expansion.
RCH=CH2 + H2 + CO → RCH2−CH2CHO Rh-based hydroformylation underpins the industrial production of products as diverse as detergents, fragrances, and some drugs. Rhodium based catalysts have 1000 to 10000 times higher activity for hydroformylation than cheaper cobalt carbonyl-based catalysts, allowing reactions at lower temperatures and pressures. Rhodium is also known to catalyze many reactions involving hydrogen gas and hydrosilanes. These include hydrogenations and hydrosilylations of alkenes. Rhodium metal, but not rhodium complexes, catalyzes the hydrogenation of benzene to cyclohexane.
Methods similar to those first developed by Roselius have continued to dominate, and are sometimes known as the direct organic solvent method. However, because of health concerns regarding benzene (which is recognized today as a carcinogen), other solvents, such as dichloromethane or ethyl acetate, are now used. The unroasted (green) beans are first steamed and then rinsed with the solvent which extracts the caffeine, while leaving other constituents largely unaffected. The process is repeated between 8 and 12 times until the caffeine content meets the required standard (97% of caffeine removed according to the US standard, or 99.9% caffeine-free by mass per the EU standard).
Their subsequent work shows how the SREBP pathway regulates the expression of many genes that control lipid formation and metabolism and body fuel allocation. Cholesterol synthesis can be turned off when cholesterol levels are high. HMG-CoA reductase contains both a cytosolic domain (responsible for its catalytic function) and a membrane domain which senses signals for its degradation. Increasing concentrations of cholesterol (and other sterols) cause a change in this domain's oligomerization state, making it more susceptible to destruction by the proteasome. This enzyme's activity can also be reduced by phosphorylation by an AMP-activated protein kinase. Because this kinase is activated by AMP, which is produced when ATP is hydrolyzed, it follows that cholesterol synthesis is halted when ATP levels are low.
Sources: en.wikipedia.org
=== Marijuana === Moore supported legislation introduced and passed during the 2022 legislative session that created a ballot referendum to legalize recreational marijuana in Maryland, and another bill that would regulate marijuana possession should the referendum pass in November. During his 2022 gubernatorial campaign, Moore talked about implementing a recreational cannabis industry with a focus on equity "so that communities that have experienced the greatest disparities benefit the most." Question 4 passed with 67.2 percent of voters approving the measure on November 8, 2022. In January 2023, Moore signed an executive order releasing $46.5 million to start developing the framework for a recreational marijuana industry in the state, with a majority of the released funds going toward grants for minority-owned firms. In May 2023, he signed a bill regulating the state's recreational marijuana industry. In October 2022, Moore praised President Joe Biden's pardon of thousands of people convicted of marijuana possession under federal law, and said that he would "fight to expunge the records of those arrested for marijuana possession [as governor]". In June 2024, Moore signed an executive order pardoning about 100,000 people with low-level cannabis-related convictions in Maryland. In June 2025, he pardoned an additional 6,900 individuals convicted of simple cannabis possession. In May 2023, Moore allowed a bill that prohibits police from stopping a vehicle solely based on if they smell marijuana to become law without his signature.
== History == EFLM was created from the merger of two precursor organisations, The Federation of European Societies of Clinical Chemistry (FESCC), (a European representative of the International Federation of Clinical Chemistry and Laboratory Medicine, IFCC) and the European Community Confederation of Clinical Chemistry (EC4) at the EuroMedlab meeting in Amsterdam in 2007. Both precursor organizations arose in the 1970s. The increasing overlap between the European Union, represented by EC4 and FESCC, representing geographical Europe, meant that merger was appropriate.
== Pharmacology == Similar to other benzodiazepines clotiazepam has anxiolytic, sedative, hypnotic, amnesic, anticonvulsant and muscle relaxant pharmacological properties. Clotiazepam binds to the benzodiazepine site of the GABAA receptor where it acts as a full agonist; this action results in an enhanced GABA inhibitory effect at the GABAA receptor which results in the pharmacological effects of clotiazepam. Clotiazepam has a short elimination half-life and is less prone to accumulation after repeated dosing compared to longer-acting benzodiazepine agents. It is metabolised via oxidation. Clotiazepam is metabolised to hydroxy-clotiazepam and desmethyl-clotiazepam. After oral ingestion of a single 5 mg dose of clotiazepam by three healthy volunteers the drug was rapidly absorbed. The elimination half-life of the drug and its metabolites range from 6.5 hours to 18 hours. Clotiazepam is 99 percent bound to plasma protein. In elderly men the elimination half-life is longer and in elderly women the volume of distribution is increased. Individuals with liver impairment have a reduced volume of distribution as well as a reduced total clearance of clotiazepam; renal impairment does not affect the kinetics of clotiazepam. The dose equivalent to 10 mg diazepam is thought to be between 5 and 10 mg clotiazepam.
Bicalutamide monotherapy has been found to decrease circulating levels of prostate-specific antigen (PSA), a marker of prostate cancer growth, by 57% at 10 mg/day, 73% at 30 mg/day, 90% at 50 mg/day, 97% at 100 mg/day, and 97% at 150 mg/day, while a 97% reduction in PSA is observed with 50 mg/day bicalutamide as a part of CAB. It has also been reported that bicalutamide monotherapy decreases median circulating levels of PSA at 3 months by 86.7% at 100 mg/day, 91.1% at 150 mg/day, and 93.8% at 200 mg/day (relative to 94–97% for castration). Above a bicalutamide monotherapy dosage of 200 mg/day, up to 600 mg/day, decreases in PSA levels reach a plateau. In a study of very-high-dose bicalutamide monotherapy, decreases in PSA levels after 12 weeks were approximately 93% with 300 mg/day, 96% with 450 mg/day, 96% with 600 mg/day, and 96% with castration. Earlier studies with bicalutamide instead assessed changes in prostatic acid phosphatase (PAP) levels; proportions of patients with decreases of PAP of greater than or equal to 50% were 33% with 10 mg/day, 53% with 30 mg/day, and 83% with 50 mg/day bicalutamide. PSA is a more sensitive and specific prostate cancer tumor marker than PAP and subsequent studies employed PSA. Despite the high medication levels that are achieved, due to their relatively low affinities for the AR, it has been suggested that 5 to 10% of DHT may remain unblocked in the prostate gland with CAB using standard doses of first-generation NSAAs.
Sources: en.wikipedia.org
两者都是 GHS-R1a 激动剂，但 ipamorelin 在研究中显示出更高的生长激素释放选择性。早期资料显示它对皮质醇、催乳素与食欲的刺激弱于 GHRP-6。这些差异是相对程度，而非绝对区分。
公开资料中它主要以研究用肽的形式出现，未获主要监管机构批准用于治疗。可得材料通常标注仅供研究使用。任何临床用途的宣称都缺少监管依据。
序列中的 Aib 与 D-2-Nal 等非天然残基可提高对肽酶的抵抗能力，并影响受体结合的构象。这类修饰在合成肽设计中较为常见。它们也使常规氨基酸分析需要额外步骤才能确认序列。
Aib 即 α-氨基异丁酸，是一种非蛋白质源氨基酸，其侧链为两个甲基。它在肽链中倾向于诱导螺旋构象并限制骨架的柔性。这种刚性被认为有助于抵抗蛋白酶切割。